2011-04-08

[DIV28SUPER] NIDA Neuroscience Update April 8, 2011

Table of Contents

I. Save the Date for NIDA Mini-Convention

II. Upcoming Request for Applications (RFAs)

 

I. Save the Date for NIDA Mini-Convention

Friday November 11, 2011

Washington, DC

National Institute on Drug Abuse Frontiers in Addiction Research Mini-Convention

 

The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session for early career investigators.  The agenda this year includes:

 

8:00 – 8:15         Welcome: NIDA Director

 

8:15 – 9:35          Autism, Addiction, and MeCP2

 

9:35-10:10          Jacob P. Waletzky Memorial Lecture

 

10:30-12:15       Synapse Organization and Plasticity in Drug Addiction

 

12:15- 2:15         Early Career Investigators Poster Session

 

2:15-4:10            Using Optogenetic Tools to Shed Light on the Neural Mechanisms of Addiction

 

4:20-5:40            Neurobiology of Behavioral and Emotional Regulation/Dysregulation

 

Seating is limited. Please register online: https://seiservices.com/nida/frontiers2011/

 

 

II. Upcoming Request for Applications (RFAs) Please read announcements for details.

 

Bueprint for Neuroscience Research Science Education Award RFA-DA-11-013 (R25)

National Institutes of Health (NIH) www.nih.gov

Application Receipt Date(s): April 11, 2011

 

Medication Initiative for Tobacco Dependence (MITD): A New Product Development Partnership (PDP)(UH2/UH3) RFA-DA-11-015 (UH2/UH3)

National Institute on Drug Abuse

Application Receipt Date(s): April 26, 2011

 

The Placebo Effect: Mechanisms and Methodology RFA-DA-12-003 (R01)
RFA-DA-12-004 (R21)

Application Receipt Date(s): May 24, 2011

 

2011 NIDA Avant-Garde Award Program for HIV/AIDS Research RFA-DA-11-002 (DP1)

Application Receipt Date(s): May 26, 2011

 

Exploring Drugs of Abuse and Transgenerational Phenotypes
RFA-DA-12-006 (R01)
National Institute on Drug Abuse
Application Receipt Date(s): July 29, 2011

 

Medications Development Program Projects for Substance-Related Disorders  RFA-DA-12-005 (P01)

National Institute on Drug Abuse

Application Receipt Date(s): July 29, 2011

 

HIV/AIDS Implementation Science Targeting Drug Using Populations: A Collaboration with PEPFAR RFA-DA-12-002 (R01)

Application Receipt Date(s): August 01, 2011 

 

NIH Blueprint for Neuroscience Research Grand Challenge: Developing Novel Drugs for Disorders of the Nervous System RFA-NS-12-002 (U01)

National Institutes of Health (NIH) (http://www.nih.gov)

Application Receipt Date: August 10, 2010 

 

--------------------

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

 

 

No comments:

Post a Comment